ESGCT Conference Takeaways: A specialty laboratory perspective

Discover the latest innovations in cell and gene therapy via Cerba Research’s highlights of ESGCT.

Seven C’s That Can Help on Your Next ED Shift

PHILADELPHIA — Want to make better use of your brain on your next emergency department (ED) shift? Follow these seven C’s, psychologist Helena Boschi, PhD,

October 10, 2023

Novartis acquires Chinook for $3.2bn to boost kidney disease pipeline – Pharmaceutical Technology

The shareholders would also be eligible to receive an additional $4 per share contingent (totalling $300m) on regulatory milestones. Image Credit: JHVEPhoto / Shutterstock. Novartis

August 14, 2023

What’s the Better Option for High-Risk Prostate Cancer — Radiation or Surgery?

SAN FRANCISCO — Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a radiotherapy-based strategy compared with a

February 15, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.